Stockreport

Lexaria's GLP-1 Human Pilot Study #3 Completes Dosing as Scheduled [Yahoo! Finance]

Lexaria Bioscience Corp.  (LEXX) 
PDF KELOWNA, BC / ACCESSWIRE / November 25, 2024 / Lexaria Bioscience Corp. (Nasdaq:LEXX)(Nasdaq:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery pl [Read more]